March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate ...
After hours: March 19 at 5:17:25 p.m. EDT Loading Chart for ALTS ...
Pantheon closed its Secondary Opportunities Fund II (PSOF II) and related vehicles at $1.1 billion – a 76.3% jump from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback